510(k) K802886
K802886 is an FDA 510(k) premarket notification submitted by Nuclear Diagnostics, Inc. for the device "NUCLI-PAP TM-(I125)-PAP RADIOIMMUNOAS-". The FDA issued a decision of Substantially Equivalent on Jan 28, 1981. The device falls under product code JFH (Acid Phosphatase (Prostatic), Tartrate Inhibited), a Class II device regulated under 21 CFR 862.1020. Nuclear Diagnostics, Inc. has 23 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Jan 28, 1981
- Date Received
- Nov 17, 1980
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Acid Phosphatase (Prostatic), Tartrate Inhibited
- Device Class
- Class II
- Regulation Number
- 862.1020
- Review Panel
- CH
- Submission Type
- 510(k) Exempt
Need the full FDA record for Nuclear Diagnostics, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.